From the publishers of JADPRO
CAR T-Cell Therapy
Resource Center
Menu
Resources
Videos
Videos
Fast Facts
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Fast Facts #10: Viral Vectors and CAR T-Cell Therapy
Last Updated: Wednesday, March 16, 2022
Test your knowledge on viral vectors
Last Updated: Wednesday, March 16, 2022
Loading...
Advertisement
News & Literature Highlights
Critical Reviews in Oncology/Hematology
In vivo generation of CAR-T cells: Current obstacles, strategic solutions, and clinical translation
Cytotherapy
Impact of blinatumomab and inotuzumab exposure on apheresis composition for CAR T in patients with B-cell acute lymphoblastic leukemia
Bone Marrow Transplantation
Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma
Exploratory Research in Clinical and Social Pharmacy
Transitions of care between pediatric onco-hematology and intensive care units: An exploratory study of healthcare professionals' perceptions and practices in medication management
Frontiers in Immunotherapy
Smart control of CAR-T cells: Emerging strategies for safer and more effective cancer immunotherapy
Molecular Therapy
CDK4/6 inhibition enhances CAR-T cell therapy in solid tumors
Nature Medicine
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: A phase 1 study
Frontiers in Oncology
Safety and efficacy of CAR T-cell therapy in central nervous system lymphoma: A systematic review and meta-analysis
Journal of Translational Medicine
Asiaticoside enhances the antitumor efficacy of MSLN-targeted CAR-T cells in ovarian cancer
Trends in Cancer
In vivo CAR T cell engineering: Design principles and open questions
Advertisement
Case Studies
Identifying and Managing CAR T-Associated Hemophagocytic Lymphohistiocytosis Following Dual-Targeted CAR T-Cell Therapy
Prophylactic Tocilizumab in Selected High-Risk or Outpatient CAR-T Populations
Hemophagocytic Lymphohistiocytosis Following CAR T-Cell Therapy in a Patient With Multiple Myeloma
Fast Facts
Fast Facts #12: BCMA Targets
Advertisement
Quizzes
Test your knowledge of CAR T-associated HLH following dual-targeted CAR T-cell therapy
Test your knowledge of prophylactic strategies in selected high-risk or outpatient CAR-T populations
How much have you learned this year?